SKYE
SKYE
NASDAQ · Biotechnology

Skye Bioscience Inc

$0.58
-0.04 (-6.63%)
As of Mar 29, 10:54 PM ET ·
Financial Highlights (FY 2025)
Revenue
3.64M
Net Income
720.4K
Gross Margin
63.0%
Profit Margin
19.8%
Rev Growth
+15.7%
D/E Ratio
0.34
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 63.0% 63.0% 63.0%
Operating Margin 24.1% 24.5% 24.5%
Profit Margin 19.8% 20.8% 24.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.64M 3.84M 3.77M
Gross Profit 2.29M 2.42M 2.38M
Operating Income 876.5K 940.2K 924.5K
Net Income 720.4K 800.4K 930.4K
Gross Margin 63.0% 63.0% 63.0%
Operating Margin 24.1% 24.5% 24.5%
Profit Margin 19.8% 20.8% 24.7%
Rev Growth +15.7% +20.7% +9.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.10M 5.57M 5.69M
Total Equity 15.19M 15.89M 15.26M
D/E Ratio 0.34 0.35 0.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.38M 1.54M 1.32M
Free Cash Flow 559.4K 545.0K 561.2K